Application Nr Approved Date Route Status External Links
NDA022527 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Gilenya Is Indicated For The Treatment Of Relapsing Forms Of Multiple Sclerosis (Ms), To Include Clinically Isolated Syndrome, Relapsing-Remitting Disease, And Active Secondary Progressive Disease, In Patients 10 Years Of Age And Older. Gilenya Is A Sphingosine 1-Phosphate Receptor Modulator Indicated For The Treatment Of Relapsing Forms Of Multiple Sclerosis (Ms), To Include Clinically Isolated Syndrome, Relapsing-Remitting Disease, And Active Secondary Progressive Disease, In Patients 10 Years Of Age And Older. ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Fingolimod Hydrochloride FINGOLIMOD HYDROCHLORIDE ZINC1542002

Comments